USPSTF Recommends Screening for Syphilis in Pregnancy

Share this content:
USPSTF Recommends Screening for Syphilis in Pregnancy
USPSTF Recommends Screening for Syphilis in Pregnancy

TUESDAY, Feb. 6, 2018 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) concludes that there is considerable net benefit to screening for syphilis infection in pregnant women. These findings form the basis of a draft recommendation statement, published Feb. 6 by the USPSTF.

Researchers from the USPSTF conducted a systematic review to examine the evidence for the effectiveness of screening to reduce the incidence of congenital syphilis or other adverse pregnancy outcomes of syphilis, and the harms of screening in pregnancy.

The researchers found that there was adequate evidence that screening tests can accurately detect syphilis infection in pregnant women. Convincing evidence was found that universal screening for syphilis infection in pregnant women reduces the incidence of congenital syphilis and adverse outcomes associated with maternal infection. Although screening pregnant women for syphilis may result in potential harms, including anxiety and harms of treatment with antibiotic medications, it was concluded that these were no greater than small. Therefore, the USPSTF concludes that there is considerable net benefit for screening for syphilis infection in pregnant women. These findings form the basis of a draft recommendation statement, which is available for comment from Feb. 6 to March 5, 2018.

"It's important to screen early in pregnancy, when treatment is most effective in preventing the baby from getting syphilis," Task Force member Melissa A. Simon, M.D., M.P.H., said in a statement.

Draft Evidence Review
Draft Recommendation Statement
Comment on Recommendation

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »